Visser GW - Search Results

1

186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.

Gerretsen M, Visser GW, van Walsum M, Meijer CJ, Snow GB, van Dongen GA. Gerretsen M, et al. Among authors: visser gw. Cancer Res. 1993 Aug 1;53(15):3524-9. Cancer Res. 1993. PMID: 8339258

2

Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro.

Vrouenraets MB, Visser GW, Stigter M, Oppelaar H, Snow GB, van Dongen GA. Vrouenraets MB, et al. Among authors: visser gw. Int J Cancer. 2002 Apr 10;98(5):793-8. doi: 10.1002/ijc.10281. Int J Cancer. 2002. PMID: 11920653

3

Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.

Verel I, Visser GW, Boerman OC, van Eerd JE, Finn R, Boellaard R, Vosjan MJ, Stigter-van Walsum M, Snow GB, van Dongen GA. Verel I, et al. Among authors: visser gw. Cancer Biother Radiopharm. 2003 Aug;18(4):655-61. doi: 10.1089/108497803322287745. Cancer Biother Radiopharm. 2003. PMID: 14503961

4

Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.

Verel I, Visser GW, Boellaard R, Boerman OC, van Eerd J, Snow GB, Lammertsma AA, van Dongen GA. Verel I, et al. Among authors: visser gw. J Nucl Med. 2003 Oct;44(10):1663-70. J Nucl Med. 2003. PMID: 14530484 Free article.

5

Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2.

van Dongen GA, Leverstein H, Roos JC, Quak JJ, van den Brekel MW, van Lingen A, Martens HJ, Castelijns JA, Visser GW, Meijer CJ, et al. van Dongen GA, et al. Among authors: visser gw. Cancer Res. 1992 May 1;52(9):2569-74. Cancer Res. 1992. PMID: 1568225

6

Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48.

Gerretsen M, Visser GW, Brakenhoff RH, van Walsum M, Snow GB, van Dongen GA. Gerretsen M, et al. Among authors: visser gw. Cell Biophys. 1994;24-25:135-42. doi: 10.1007/BF02789224. Cell Biophys. 1994. PMID: 7736517

7

Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol.

Visser GW, Gerretsen M, Herscheid JD, Snow GB, van Dongen G. Visser GW, et al. J Nucl Med. 1993 Nov;34(11):1953-63. J Nucl Med. 1993. PMID: 8229241 Free article.

8

Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.

van Gog FB, Visser GW, Klok R, van der Schors R, Snow GB, van Dongen GA. van Gog FB, et al. Among authors: visser gw. J Nucl Med. 1996 Feb;37(2):352-62. J Nucl Med. 1996. PMID: 8667076 Free article.

9

High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.

van Gog FB, Visser GW, Stroomer JW, Roos JC, Snow GB, van Dongen GA. van Gog FB, et al. Among authors: visser gw. Cancer. 1997 Dec 15;80(12 Suppl):2360-70. Cancer. 1997. PMID: 9406684

10

Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy.

Vrouenraets MB, Visser GW, Stewart FA, Stigter M, Oppelaar H, Postmus PE, Snow GB, van Dongen GA. Vrouenraets MB, et al. Among authors: visser gw. Cancer Res. 1999 Apr 1;59(7):1505-13. Cancer Res. 1999. PMID: 10197621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters